352 related articles for article (PubMed ID: 11856686)
1. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
Yoon HC; Miller FJ
AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
[TBL] [Abstract][Full Text] [Related]
2. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR
J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039
[TBL] [Abstract][Full Text] [Related]
4. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.
Ohman EM; Kleiman NS; Gacioch G; Worley SJ; Navetta FI; Talley JD; Anderson HV; Ellis SG; Cohen MD; Spriggs D; Miller M; Kereiakes D; Yakubov S; Kitt MM; Sigmon KN; Califf RM; Krucoff MW; Topol EJ
Circulation; 1997 Feb; 95(4):846-54. PubMed ID: 9054741
[TBL] [Abstract][Full Text] [Related]
5. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study.
Drescher P; Crain MR; Rilling WS
J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis.
Schweizer J; Kirch W; Koch R; Müller A; Hellner G; Forkmann L
Angiology; 2000 Nov; 51(11):913-23. PubMed ID: 11103860
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke.
Memon MZ; Natarajan SK; Sharma J; Mathews MS; Snyder KV; Siddiqui AH; Hopkins LN; Levy EI
J Neurosurg; 2011 Apr; 114(4):1008-13. PubMed ID: 20868216
[TBL] [Abstract][Full Text] [Related]
8. Utilization of GP IIb/IIIa inhibitors in peripheral percutaneous interventions: current applications and in-hospital outcomes at a tertiary referral center.
Shammas NW; Dippel EJ; Shammas GA; Kumar A; Jerin M; Kennedy L
J Invasive Cardiol; 2008 Jun; 20(6):266-9. PubMed ID: 18523317
[TBL] [Abstract][Full Text] [Related]
9. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
Pancioli AM; Broderick J; Brott T; Tomsick T; Khoury J; Bean J; del Zoppo G; Kleindorfer D; Woo D; Khatri P; Castaldo J; Frey J; Gebel J; Kasner S; Kidwell C; Kwiatkowski T; Libman R; Mackenzie R; Scott P; Starkman S; Thurman RJ;
Stroke; 2008 Dec; 39(12):3268-76. PubMed ID: 18772447
[TBL] [Abstract][Full Text] [Related]
10. Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots.
Meunier JM; Holland CK; Pancioli AM; Lindsell CJ; Shaw GJ
Thromb Res; 2009; 123(3):528-36. PubMed ID: 18619651
[TBL] [Abstract][Full Text] [Related]
11. Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis.
Schweizer J; Kirch W; Koch R; Müller A; Hellner G; Forkmann L
Angiology; 2003; 54(2):155-61. PubMed ID: 12678189
[TBL] [Abstract][Full Text] [Related]
12. Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial.
Dery JP; Campbell ME; Mathias J; Pieper KS; Harrington RA; Madan M; Gibson CM; Tolleson TR; O'Shea JC; Tcheng JE;
Catheter Cardiovasc Interv; 2007 Jul; 70(1):43-50. PubMed ID: 17203469
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy.
Deshmukh VR; Fiorella DJ; Albuquerque FC; Frey J; Flaster M; Wallace RC; Spetzler RF; McDougall CG
Neurosurgery; 2005; 56(1):46-54; discussion 54-5. PubMed ID: 15617585
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of Rt-pa thrombolysis combined with PGE1 in patients with peripheral arterial occlusions.
Kröger K; Buss C; Rudofsky G
Angiology; 2000 May; 51(5):377-84. PubMed ID: 10826854
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIb/IIIa inhibitors during rescue percutaneous coronary intervention in acute myocardial infarction.
Gruberg L; Suleiman M; Kapeliovich M; Hammerman H; Grenadier E; Boulus M; Amikam S; Markiewicz W; Beyar R
J Invasive Cardiol; 2006 Feb; 18(2):59-62. PubMed ID: 16446517
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.
Lincoff AM; Kleiman NS; Kereiakes DJ; Feit F; Bittl JA; Jackman JD; Sarembock IJ; Cohen DJ; Spriggs D; Ebrahimi R; Keren G; Carr J; Cohen EA; Betriu A; Desmet W; Rutsch W; Wilcox RG; de Feyter PJ; Vahanian A; Topol EJ;
JAMA; 2004 Aug; 292(6):696-703. PubMed ID: 15304466
[TBL] [Abstract][Full Text] [Related]
17. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
18. Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial.
Brener SJ; Zeymer U; Adgey AA; Vrobel TR; Ellis SG; Neuhaus KL; Juran N; Ivanc TB; Ohman EM; Strony J; Kitt M; Topol EJ
J Am Coll Cardiol; 2002 Feb; 39(3):377-86. PubMed ID: 11823073
[TBL] [Abstract][Full Text] [Related]
19. Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors.
Iskandar SB; Kasasbeh ES; Mechleb BK; Garcia I; Jackson A; Fahrig S; Albalbissi K; Henry PD
J Interv Cardiol; 2006 Aug; 19(4):356-63. PubMed ID: 16881986
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.
Kleiman NS; Tracy RP; Talley JD; Sigmon K; Joseph D; Topol EJ; Califf RM; Kitt M; Ohman EM
J Thromb Thrombolysis; 2000 Jan; 9(1):5-12. PubMed ID: 10590183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
